BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225-232. [PMID: 10903602 DOI: 10.1097/00000658-200008000-00013] [Cited by in Crossref: 389] [Cited by in F6Publishing: 345] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Xiong L, Li Y. Short-term effects of nedaplatin plus futraful chemotherapy in treatment of advanced esophageal carcinoma. Chin -Ger J Clin Oncol 2009;8:273-5. [DOI: 10.1007/s10330-009-0030-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Umezawa H, Nakao J, Matsutani T, Kuwahara H, Taga M, Ogawa R. Usefulness of the Clavien-Dindo Classification in Understanding the Limitations and Indications of Larynx-preserving Esophageal Reconstruction. Plast Reconstr Surg Glob Open 2016;4:e1113. [PMID: 27975019 DOI: 10.1097/GOX.0000000000001113] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yamashita H, Omori M, Takenaka R, Okuma K, Kobayashi R, Ohtomo K, Nakagawa K. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study. Radiother Oncol 2014;113:182-7. [PMID: 25466372 DOI: 10.1016/j.radonc.2014.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
4 Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238:339-347; discussion 347-348. [PMID: 14501500 DOI: 10.1097/01.sla.0000086545.45918.ee] [Cited by in Crossref: 73] [Cited by in F6Publishing: 88] [Article Influence: 3.8] [Reference Citation Analysis]
5 Ulrich B, Zahedi A. Technical aspects and results of the transhiatal resection in adenocarcinomas of the gastroesophageal junction. Dis Esophagus 2001;14:115-9. [PMID: 11553220 DOI: 10.1046/j.1442-2050.2001.00167.x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
6 Law S, Kwong DL, Wong KH, Kwok KF, Wong J. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 2006;10:1301-11. [PMID: 17114016 DOI: 10.1016/j.gassur.2006.06.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
7 Igaki H, Kato H, Tachimori Y, Nakanishi Y, Shimoda T. Surgery for clinical T3 carcinomas of the upper thoracic oesophagus and the need for new strategies. British Journal of Surgery 2005;92:1235-40. [DOI: 10.1002/bjs.5081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
8 Matsubara T, Hirahara N, Zotani H, Tabara N, Tabara H, Tajima Y. Three-dimensional computed tomography image-oriented successful thoracoscopic subtotal esophagectomy for an esophageal cancer patient with an anomalous right superior pulmonary vein: A case report. Int J Surg Case Rep 2020;76:178-82. [PMID: 33038843 DOI: 10.1016/j.ijscr.2020.09.196] [Reference Citation Analysis]
9 Song Q, Yang W, Meng Z, Wang J. Protocol for a systematic review and meta-analysis of Kang-ai injection for patients with oesophageal cancer. Medicine (Baltimore) 2020;99:e22148. [PMID: 32899102 DOI: 10.1097/MD.0000000000022148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Huang Y, Wang H, Luo G, Zhang Y, Wang L, Li K. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma. Int J Surg 2017;38:41-7. [PMID: 28027995 DOI: 10.1016/j.ijsu.2016.12.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
11 Wang X, Niu H, Fan Q, Lu P, Ma C, Liu W, Liu Y, Li W, Hu S, Ling Y, Guo L, Ying J, Huang J. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma. Oncotarget 2016;7:24744-51. [PMID: 27013591 DOI: 10.18632/oncotarget.8271] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
12 Sato Y, Motoyama S, Nanjo H, Wakita A, Yoshino K, Sasaki T, Nagaki Y, Liu J, Imai K, Saito H, Minamiya Y. CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2016;23:936-42. [PMID: 26464192 DOI: 10.1245/s10434-015-4909-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
13 Yuda M, Yamashita K, Okamura A, Hayami M, Fukudome I, Toihata T, Imamura Y, Mine S, Ishizuka N, Watanabe M. Influence of Preoperative Oropharyngeal Microflora on the Occurrence of Postoperative Pneumonia and Survival in Patients Undergoing Esophagectomy for Esophageal Cancer. Ann Surg 2020;272:1035-43. [PMID: 30946087 DOI: 10.1097/SLA.0000000000003287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
14 Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 2002;94:929-933. [PMID: 11920460 DOI: 10.1002/cncr.10329] [Cited by in Crossref: 163] [Cited by in F6Publishing: 103] [Article Influence: 8.2] [Reference Citation Analysis]
15 Atsumi K, Shioyama Y, Nakamura K, Nomoto S, Ohga S, Yoshitake T, Nonoshita T, Ueda M, Hirata H, Honda H. Predictive factors of esophageal stenosis associated with tumor regression in radiation therapy for locally advanced esophageal cancer. J Radiat Res. 2010;51:9-14. [PMID: 19801888 DOI: 10.1269/jrr.09073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Chen J, Cai W, Zheng X, Chen Y, Lin Y, Chen X, Zhu K, Chen C. The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy. Radiotherapy and Oncology 2017;123:382-6. [DOI: 10.1016/j.radonc.2017.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Minato T, Yamamoto Y, Seike J, Yoshida T, Yamai H, Takechi H, Yuasa Y, Furukita Y, Goto M, Bando Y. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2013;20:209-217. [PMID: 22847125 DOI: 10.1245/s10434-012-2535-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
18 Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, Feng YB, Shi ZZ, Xu X, Han YL, Cai Y, Dong JT, Zhan QM, Wu M, Wang MR. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 2008;47:127-36. [PMID: 17990328 DOI: 10.1002/gcc.20514] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
19 Zhong S, Yan H, Chen Z, Li Y, Shen Y, Wang Y, Li L, Sheng S, Wang Y. Overexpression of TAF1L Promotes Cell Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma. J Cancer 2019;10:979-89. [PMID: 30854104 DOI: 10.7150/jca.26504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12-30. [PMID: 16378161 DOI: 10.1245/aso.2005.12.025] [Cited by in Crossref: 152] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
21 Hagens ERC, Künzli HT, van Rijswijk A, Meijer SL, Mijnals RCD, Weusten BLAM, Geijsen ED, van Laarhoven HWM, van Berge Henegouwen MI, Gisbertz SS. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study. Surg Endosc 2020;34:4347-57. [DOI: 10.1007/s00464-019-07205-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Li J, Tang Y, Huang L, Yu QQ, Hu GY, Chen C, Zhang P, Yuan XL. Genetic variants in CHEK1 gene are associated with the prognosis of thoracic esophageal squamous cell carcinoma patients treated with radical resection. J Huazhong Univ Sci Technolog Med Sci 2016;36:828-33. [PMID: 27924519 DOI: 10.1007/s11596-016-1670-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Koyanagi K, Kanamori K, Ninomiya Y, Yatabe K, Higuchi T, Yamamoto M, Tajima K, Ozawa S. Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan. Cancers (Basel) 2020;13:E51. [PMID: 33375499 DOI: 10.3390/cancers13010051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Tsuchikawa T, Ikeda H, Cho Y, Miyamoto M, Shichinohe T, Hirano S, Kondo S. Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival. Clin Exp Immunol. 2011;164:50-56. [PMID: 21352198 DOI: 10.1111/j.1365-2249.2010.04311.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
25 Glickman JN. Section II: Pathology and pathologic staging of esophageal cancer. Seminars in Thoracic and Cardiovascular Surgery 2003;15:167-79. [DOI: 10.1016/s1043-0679(03)70025-2] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
26 Bau D, Tsai C, Wu C. Role of the XRCC5/XRCC6 dimer in carcinogenesis and pharmacogenomics. Pharmacogenomics 2011;12:515-34. [DOI: 10.2217/pgs.10.209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
27 Lordick F. Neoadjuvante Therapie von Plattenepithelkarzinomen des Ösophagus: Was ist „evidence based“? Chirurg 2005;76:1025-32. [DOI: 10.1007/s00104-005-1098-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
28 Kitamura Y, Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Fujino Y, Tominaga M, Nakamura T, Suzuki S, Kakeji Y. Impact of Lymph Node Ratio on Survival Outcome in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy. Ann Surg Oncol 2021;28:4519-28. [PMID: 33393049 DOI: 10.1245/s10434-020-09451-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Takeuchi H, Kitagawa Y. Sentinel node navigation surgery for esophageal cancer. Gen Thorac Cardiovasc Surg 2008;56:393-6. [DOI: 10.1007/s11748-008-0264-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chen J, Wu S, Zheng X, Pan J, Zhu K, Chen Y, Li J, Liao L, Lin Y, Liao Z. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection. BMC Surg 2014;14:110. [PMID: 25527100 DOI: 10.1186/1471-2482-14-110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
31 Chen X, Chen J, Zheng X, Chen Y, Lin Y, Zheng Q, Zhu K, Pan J. Prognostic factors in patients with thoracic esophageal carcinoma staged pT1-4aN0M0 undergone esophagectomy with three-field lymphadenectomy. Ann Transl Med 2015;3:282. [PMID: 26697442 DOI: 10.3978/j.issn.2305-5839.2015.11.05] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Soutome S, Hasegawa T, Yamguchi T, Aoki K, Kanamura N, Mukai T, Yamazoe J, Nishikawa M, Isomura E, Hoshi K, Umeda M; Joint Research Committee of Japanese Society of Oral Care. Prevention of postoperative pneumonia by perioperative oral care in patients with esophageal cancer undergoing surgery: a multicenter retrospective study of 775 patients. Support Care Cancer 2020;28:4155-62. [PMID: 31897780 DOI: 10.1007/s00520-019-05242-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
33 Sakurai Y, Kanaya S, Komori Y, Uyama I. Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy? Esophagus 2009;6:149-54. [DOI: 10.1007/s10388-009-0196-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Zhao Y, Jiang Y, Wang R, Zheng X, Wang X, Jin B, Lu Y, Qiao T, Hong L, Fan D. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Ann Surg Oncol 2007;14:2621-7. [PMID: 17570016 DOI: 10.1245/s10434-007-9416-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
35 Lam AK. Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice. Hum Pathol 2021;108:100-12. [PMID: 33157124 DOI: 10.1016/j.humpath.2020.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Vallböhmer D, Brabender J, Metzger R, Hölscher AH. Genetics in the Pathogenesis of Esophageal Cancer: Possible Predictive and Prognostic Factors. J Gastrointest Surg 2010;14:75-80. [DOI: 10.1007/s11605-009-1021-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
37 Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S. Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy. Dis Esophagus. 2017;30:1-6. [PMID: 26727414 DOI: 10.1111/dote.12451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
38 Arméstar F, Mesalles E, Font A, Arellano A, Roca J, Klamburg J, Fernández-Llamazares J. [Serious postoperative complications after esophagectomy for esophageal carcinoma: analysis of risk factors]. Med Intensiva 2009;33:224-32. [PMID: 19624996 DOI: 10.1016/s0210-5691(09)71756-5] [Reference Citation Analysis]
39 Hori K, Okada H, Kawahara Y, Takenaka R, Shimizu S, Ohno Y, Onoda T, Sirakawa Y, Naomoto Y, Yamamoto K. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer. Am J Gastroenterol. 2011;106:858-866. [PMID: 21468010 DOI: 10.1038/ajg.2010.489] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
40 Kosuga T, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, Otsuji E. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection. World J Surg 2011;35:798-804. [PMID: 21312037 DOI: 10.1007/s00268-011-0978-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
41 Liu WY, Wu XU, Liao CQ, Shen J, Li J. Apoptotic effect of gambogic acid in esophageal squamous cell carcinoma cells via suppression of the NF-κB pathway. Oncol Lett 2016;11:3681-5. [PMID: 27284372 DOI: 10.3892/ol.2016.4437] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
42 Sauvanet A, Mariette C, Thomas P, Lozac’h P, Segol P, Tiret E, Delpero JR, Collet D, Leborgne J, Pradère B. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg. 2005;201:253-262. [PMID: 16038824 DOI: 10.1016/j.jamcollsurg.2005.02.002] [Cited by in Crossref: 165] [Cited by in F6Publishing: 160] [Article Influence: 9.7] [Reference Citation Analysis]
43 Lerut T, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am 2008;17:485-502, vii-viii. [PMID: 18486879 DOI: 10.1016/j.soc.2008.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
44 Schmidt M, Bollschweiler E, Dietlein M, Mönig SP, Kobe C, Vallboehmer D, Eschner W, Hölscher A, Schicha H. Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy. Eur J Nucl Med Mol Imaging 2009;36:735-44. [DOI: 10.1007/s00259-008-1011-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
45 Law S, Wong J. The current management of esophageal cancer. Adv Surg 2007;41:93-119. [PMID: 17972559 DOI: 10.1016/j.yasu.2007.05.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
46 Oshikiri T, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. Postoperative recurrent laryngeal nerve palsy is associated with pneumonia in minimally invasive esophagectomy for esophageal cancer. Surg Endosc 2021;35:837-44. [PMID: 32086619 DOI: 10.1007/s00464-020-07455-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
47 Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer 2019;19:662. [PMID: 31272485 DOI: 10.1186/s12885-019-5761-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
48 Yamashita H, Seto Y, Takenaka R, Okuma K, Kiritooshi T, Mori K, Yamada K, Fukuda T, Kaminishi M, Abe O, Nakagawa K. Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study. PLoS One 2017;12:e0177133. [PMID: 28486551 DOI: 10.1371/journal.pone.0177133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
49 Yuda M, Nishikawa K, Ishikawa Y, Takahashi K, Kurogochi T, Tanaka Y, Matsumoto A, Tanishima Y, Mitsumori N, Ikegami T. Intraoperative nerve monitoring during esophagectomy reduces the risk of recurrent laryngeal nerve palsy. Surg Endosc 2021. [PMID: 34494155 DOI: 10.1007/s00464-021-08716-3] [Reference Citation Analysis]
50 Sgourakis G, Gockel I, Lyros O, Hansen T, Mildenberger P, Lang H. Detection of lymph node metastases in esophageal cancer. Expert Review of Anticancer Therapy 2014;11:601-12. [DOI: 10.1586/era.10.150] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
51 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
52 Tinoco R, El-kadre L, Tinoco A, Rios R, Sueth D, Pena F. Laparoscopic transhiatal esophagectomy: outcomes. Surg Endosc 2007;21:1284-7. [DOI: 10.1007/s00464-007-9267-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
53 Booka E, Haneda R, Ishii K, Kawakami T, Tsushima T, Yasui H, Onoe T, Ogawa H, Tsubosa Y. Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020;27:3163-3170. [PMID: 32314159 DOI: 10.1245/s10434-020-08440-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
54 Akutsu Y, Matsubara H, Shuto K, Shiratori T, Uesato M, Miyazawa Y, Hoshino I, Murakami K, Usui A, Kano M, Miyauchi H. Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery 2010;147:497-502. [DOI: 10.1016/j.surg.2009.10.048] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
55 Takeuchi H, Miyata H, Ozawa S, Udagawa H, Osugi H, Matsubara H, Konno H, Seto Y, Kitagawa Y. Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan. Ann Surg Oncol 2017;24:1821-7. [DOI: 10.1245/s10434-017-5808-4] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 20.2] [Reference Citation Analysis]
56 Wong J, Law S. Esophageal cancer: what price swallowing? Journal of the American College of Surgeons 2003;196:347-53. [DOI: 10.1016/s1072-7515(02)01807-0] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
57 Dong J, Feng F, Xu G, Zhang H, Hong L, Yang J. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration. Gene 2015;560:205-10. [PMID: 25659767 DOI: 10.1016/j.gene.2015.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
58 Li CL, Zhang FL, Wang YD, Han C, Sun GG, Liu Q, Cheng YJ, Jing SW, Yang CR. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett. 2013;5:355-359. [PMID: 23255948 DOI: 10.3892/ol.2012.946] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
59 Takesue T, Takeuchi H, Ogura M, Fukuda K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Kitagawa Y. A Prospective Randomized Trial of Enteral Nutrition After Thoracoscopic Esophagectomy for Esophageal Cancer. Ann Surg Oncol 2015;22 Suppl 3:S802-9. [PMID: 26219242 DOI: 10.1245/s10434-015-4767-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
60 Hayashi M, Kawakubo H, Shoji Y, Mayanagi S, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y. Analysis of the Effect of Early Versus Conventional Nasogastric Tube Removal on Postoperative Complications After Transthoracic Esophagectomy: A Single-Center, Randomized Controlled Trial. World J Surg 2019;43:580-9. [PMID: 30353406 DOI: 10.1007/s00268-018-4825-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
61 Roh MS, Lee JI, Choi PJ. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus. 2004;17:333-337. [PMID: 15569373 DOI: 10.1111/j.1442-2050.2004.00436.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
62 Ishiguro T, Kumagai Y, Ono T, Imaizumi H, Honjo H, Suzuki O, Ito T, Haga N, Kuwabara K, Sobajima J, Kumamoto K, Ishibashi K, Baba H, Ishida H, Kawano T. Usefulness of indocyanine green angiography for evaluation of blood supply in a reconstructed gastric tube during esophagectomy. Int Surg 2012;97:340-4. [PMID: 23294076 DOI: 10.9738/CC159.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.9] [Reference Citation Analysis]
63 Shirai K, Tamaki Y, Kitamoto Y, Takahashi T, Ishikawa H, Nonaka T, Murata K, Satoh Y, Higuchi K, Nakano T. Comparison of chemoradiotherapy with radiotherapy alone in patients with esophageal adenocarcinoma. J Radiat Res 2011;52:264-9. [PMID: 21343671 DOI: 10.1269/jrr.10166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
64 Soutome S, Yanamoto S, Funahara M, Hasegawa T, Komori T, Yamada SI, Kurita H, Yamauchi C, Shibuya Y, Kojima Y, Nakahara H, Oho T, Umeda M. Effect of perioperative oral care on prevention of postoperative pneumonia associated with esophageal cancer surgery: A multicenter case-control study with propensity score matching analysis. Medicine (Baltimore) 2017;96:e7436. [PMID: 28816937 DOI: 10.1097/MD.0000000000007436] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
65 Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shimizu T, Shuto K, Hayashi H, Ochiai T. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 2006;30:1441-9. [PMID: 16871357 DOI: 10.1007/s00268-005-0462-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
66 Yamashita K, Yamamoto K, Takata A, Miyazaki Y, Saito T, Tanaka K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Mano M, Nakajima K, Eguchi H, Doki Y. Continuous ghrelin infusion attenuates the postoperative inflammatory response in patients with esophageal cancer. Esophagus 2021;18:239-47. [PMID: 32856182 DOI: 10.1007/s10388-020-00776-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Aiko S, Yoshizumi Y, Ishizuka T, Sakano T, Kumano I, Sugiura Y, Maehara T. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy. Dis Esophagus 2007;20:94-101. [PMID: 17439591 DOI: 10.1111/j.1442-2050.2006.00624.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
68 Okamoto N, Ozawa S, Kitagawa Y, Shimizu Y, Kitajima M. Metachronous gastric carcinoma from a gastric tube after radical surgery for esophageal carcinoma. Ann Thorac Surg 2004;77:1189-92. [PMID: 15063232 DOI: 10.1016/j.athoracsur.2003.09.071] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
69 Tanaka K, Tsuchikawa T, Miyamoto M, Maki T, Ichinokawa M, Kubota KC, Shichinohe T, Hirano S, Ferrone S, Dosaka-Akita H. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. Int J Oncol. 2012;40:965-974. [PMID: 22134332 DOI: 10.3892/ijo.2011.1274] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
70 Zhang JL, Wang HY, Yang Q, Lin SY, Luo GY, Zhang R, Xu GL. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer. World J Gastroenterol 2015; 21(14): 4240-4247 [PMID: 25892874 DOI: 10.3748/wjg.v21.i14.4240] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Yoshikawa R, Tsujimura T, Tao L, Kamikonya N, Fujiwara Y. The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy. BMC Cancer. 2012;12:461. [PMID: 23046527 DOI: 10.1186/1471-2407-12-461] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
72 Hirasaki S, Noguchi T, Mimori K, Onuki J, Morita K, Inoue H, Sugihara K, Mori M, Hirano T. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study. Oncologist 2007;12:406-17. [PMID: 17470683 DOI: 10.1634/theoncologist.12-4-406] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
73 Huang CY, Lee CH, Tu CC, Wu CH, Huang MT, Wei PL, Chang YJ. Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis. Oncotarget 2018;9:9425-41. [PMID: 29507700 DOI: 10.18632/oncotarget.24114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
74 Triboulet J. La chirurgie du cancer de l’œsophage : pour qui, comment ? Gastroentérologie Clinique et Biologique 2005;29:546-50. [DOI: 10.1016/s0399-8320(05)82126-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
75 Nozoe T, Saeki H, Ohga T, Sugimachi K. Clinicopathologic characteristics of esophageal squamous cell carcinoma in younger patients. Ann Thorac Surg. 2001;72:1914-1917. [PMID: 11789771 DOI: 10.1016/s0003-4975(01)03091-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Narumiya K, Nakamura T, Ide H, Takasaki K. Comparison of extended esophagectomy through mini-thoracotomy/laparotomy with conventional thoracotomy/laparotomy for esophageal cancer. Jpn J Thorac Cardiovasc Surg 2005;53:413-9. [DOI: 10.1007/s11748-005-0076-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
77 Zheng YZ, Dai SQ, Li W, Cao X, Wang X, Fu JH, Lin P, Zhang LJ, Lu B, Wang JY. Comparison between different reconstruction routes in esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18(39): 5616-5621 [PMID: 23112556 DOI: 10.3748/wjg.v18.i39.5616] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
78 Konishi H, Fujiwara H, Shiozaki A, Hiramoto H, Kosuga T, Komatsu S, Ichikawa D, Okamoto K, Otsuji E. Effects of neutropenia and histological responses in esophageal squamous cell carcinoma with neo-adjuvant chemotherapy. Int J Clin Oncol 2016;21:95-101. [PMID: 26194809 DOI: 10.1007/s10147-015-0875-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
79 Tukanova K, Papi E, Jamel S, Hanna GB, McGregor AH, Markar SR. Assessment of chest wall movement following thoracotomy: a systematic review. J Thorac Dis 2020;12:1031-40. [PMID: 32274172 DOI: 10.21037/jtd.2019.12.93] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 Akutsu Y, Matsubara H. Lymph node dissection for esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:397-401. [PMID: 23529259 DOI: 10.1007/s11748-013-0237-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
81 Nozoe T, Saeki H, Ohga T, Sugimachi K. Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence. Dis Esophagus. 2002;15:145-148. [PMID: 12220422 DOI: 10.1046/j.1442-2050.2002.00241.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
82 Bhat MA, Dar MA, Lone GN, Dar AM. Use of pedicled omentum in esophagogastric anastomosis for prevention of anastomotic leak. Ann Thorac Surg 2006;82:1857-62. [PMID: 17062260 DOI: 10.1016/j.athoracsur.2006.05.101] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
83 Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425-433. [PMID: 12957254 DOI: 10.1016/s0360-3016(03)00585-6] [Cited by in Crossref: 154] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
84 Nakamura T, Hayashi K, Ota M, Eguchi R, Ide H, Takasaki K, Mitsuhashi N. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004;188:261-6. [PMID: 15450831 DOI: 10.1016/j.amjsurg.2004.06.003] [Cited by in F6Publishing: 73] [Reference Citation Analysis]
85 Ando N. Progress in multidisciplinary treatment for esophageal cancer in Japan as reflected in JCOG studies. Esophagus 2011;8:151-7. [DOI: 10.1007/s10388-011-0282-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
86 Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Inoue M, Yamamura T. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients. Oncol Rep 2012;28:446-52. [PMID: 22664791 DOI: 10.3892/or.2012.1847] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
87 Sasagawa H, Shiozaki A, Iitaka D, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K, Nakashima S, Kinoshita O, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E. Ki-67 labeling index as an independent prognostic factor in human esophageal squamous cell carcinoma. Esophagus 2012;9:195-202. [DOI: 10.1007/s10388-012-0336-6] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
88 Haneda R, Booka E, Ishii K, Kikuchi H, Hiramatsu Y, Kamiya K, Ogawa H, Yasui H, Takeuchi H, Tsubosa Y. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma. World J Surg 2021;45:1835-44. [PMID: 33620541 DOI: 10.1007/s00268-021-06016-4] [Reference Citation Analysis]
89 Dionigi G, Rovera F, Boni L, Bellani M, Bacuzzi A, Carrafiello G, Dionigi R. Cancer of the esophagus: the value of preoperative patient assessment. Expert Rev Anticancer Ther. 2006;6:581-593. [PMID: 16613545 DOI: 10.1586/14737140.6.4.581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
90 Mizutani M, Murakami G, Nawata S, Hitrai I, Kimura W. Anatomy of right recurrent nerve node: why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat 2006;28:333-8. [PMID: 16718401 DOI: 10.1007/s00276-006-0115-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
91 Takagawa R, Kunisaki C, Makino H, Kosaka T, Ono HA, Akiyama H, Shimada H. Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus. Dis Esophagus 2009;22:482-9. [PMID: 19191850 DOI: 10.1111/j.1442-2050.2008.00935.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
92 Sundelöf M, Lagergren J, Ye W. Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia. World J Surg 2008;32:2357-65. [PMID: 18716831 DOI: 10.1007/s00268-008-9698-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
93 Hattori K, Kajiyama Y, Tsurumaru M. Mutation of the p53 gene predicts lymph node metastases in Japanese patients with esophageal carcinoma: DNA and immunohistochemical analyses. Dis Esophagus 2003;16:301-6. [PMID: 14641293 DOI: 10.1111/j.1442-2050.2003.00351.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
94 Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5. [PMID: 25705637 DOI: 10.3978/j.issn.2305-5839] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
95 Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, van der Gaast A, Stassen LP, Kuipers EJ, Siersema PD. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer. 2009;100:70-76. [PMID: 19066612 DOI: 10.1038/sj.bjc.6604811] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
96 Mega S, Miyamoto M, Li L, Kadoya M, Takahashi R, Hase R, Kaneko H, Shichinohe T, Kawarada Y, Itoh T. Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. DisEsophagus. 2006;19:355-359. [PMID: 16984532 DOI: 10.1111/j.1442-2050.2006.00604.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
97 Ebihara Y, Miyamoto M, Shichinohe T, Kawarada Y, Cho Y, Fukunaga A, Murakami S, Uehara H, Kaneko H, Hashimoto H. Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. Dis Esophagus. 2004;17:150-154. [PMID: 15230729 DOI: 10.1111/j.1442-2050.2004.00393.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
98 Oshikiri T, Takiguchi G, Miura S, Takase N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda Y, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. Current status of minimally invasive esophagectomy for esophageal cancer: Is it truly less invasive? Ann Gastroenterol Surg 2019;3:138-45. [PMID: 30923783 DOI: 10.1002/ags3.12224] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
99 Suwa T, Kitagawa Y, Sasaki T, Shatari T, Sakuma M, Kitajima M. Release of band cells from the bone marrow is impaired by preoperative chemoradiation in patients with esophageal carcinoma: increased risk of postoperative pneumonia. Langenbecks Arch Surg 2006;391:461-6. [PMID: 16924531 DOI: 10.1007/s00423-006-0089-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Li J, Tang Y, Huang L, Yu Q, Hu G, Yuan X. Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection. PLoS One 2016;11:e0158613. [PMID: 27414035 DOI: 10.1371/journal.pone.0158613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Rudin Å, Flisberg P, Johansson J, Walther B, Lundberg CJF. Thoracic Epidural Analgesia or Intravenous Morphine Analgesia After Thoracoabdominal Esophagectomy: A Prospective Follow-up of 201 Patients. Journal of Cardiothoracic and Vascular Anesthesia 2005;19:350-7. [DOI: 10.1053/j.jvca.2005.03.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
102 Demeester SR. Endoscopic Mucosal Resection and Vagal-Sparing Esophagectomy for High-Grade Dysplasia and Adenocarcinoma of the Esophagus. Seminars in Thoracic and Cardiovascular Surgery 2005;17:320-5. [DOI: 10.1053/j.semtcvs.2005.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
103 Takeuchi M, Takeuchi H, Kawakubo H, Kitagawa Y. Update on the indications and results of sentinel node mapping in upper GI cancer. Clin Exp Metastasis. 2018;35:455-461. [PMID: 30132238 DOI: 10.1007/s10585-018-9934-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
104 Stein HJ, von Rahden BHA, Siewert JR. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg 2005;390:280-5. [DOI: 10.1007/s00423-004-0504-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
105 Li L, Miyamoto M, Ebihara Y, Mega S, Takahashi R, Hase R, Kaneko H, Kadoya M, Itoh T, Shichinohe T, Hirano S, Kondo S. DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma. World J Surg 2006;30:1672-9; discussion 1680-1. [PMID: 16850143 DOI: 10.1007/s00268-006-0035-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
106 Takeuchi H, Ozawa S, Shih CH, Ando N, Kitagawa Y, Ueda M, Kitajima M. Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus. Int J Cancer. 2004;109:483-490. [PMID: 14991568 DOI: 10.1002/ijc.11734] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
107 Pham TH, Perry KA, Enestvedt CK, Gareau D, Dolan JP, Sheppard BC, Jacques SL, Hunter JG. Decreased conduit perfusion measured by spectroscopy is associated with anastomotic complications. Ann Thorac Surg. 2011;91:380-385. [PMID: 21256274 DOI: 10.1016/j.athoracsur.2010.10.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
108 Couper G. Jejunostomy after oesophagectomy: a review of evidence and current practice. Proc Nutr Soc. 2011;70:316-320. [PMID: 21781359 DOI: 10.1017/s0029665111000553] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
109 Yamashita H, Okuma K, Seto Y, Mori K, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. J Surg Oncol 2009;100:435-41. [PMID: 19653240 DOI: 10.1002/jso.21361] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
110 Fokas E, Rödel C. Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer. Viszeralmedizin 2015;31:347-53. [PMID: 26989391 DOI: 10.1159/000440638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
111 Tanaka K, Yamasaki M, Kobayashi T, Yamashita K, Makino T, Saitoh T, Takahashi T, Kurokawa Y, Nakajima K, Motoori M, Kimura Y, Mori M, Eguchi H, Doki Y. Postoperative pneumonia in the acute phase is an important prognostic factor in patients with esophageal cancer. Surgery 2021;170:469-77. [PMID: 33933280 DOI: 10.1016/j.surg.2021.03.051] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Hatakeyama T, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, Murayama Y, Ikoma H, Kuriu Y, Nakanishi M, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E. A case of a superficial carcinoma of the esophagus with isolated lymph node metastasis around the abdominal aorta. Surg Today 2012;42:676-80. [PMID: 22350302 DOI: 10.1007/s00595-012-0148-2] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
113 Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K, Baba H. RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma. Br J Cancer. 2012;107:1233-1238. [PMID: 22955852 DOI: 10.1038/bjc.2012.396] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
114 de Manzoni G, Pedrazzani C, Laterza E, Pasini F, Grandinetti A, Bernini M, Ruzzenente A, Zerman G, Tomezzoli A, Cordiano C. Induction Chemoradiotherapy for Squamous Cell Carcinoma of the Thoracic Esophagus: Impact of Increased Dosage on Long-Term Results. The Annals of Thoracic Surgery 2005;80:1176-83. [DOI: 10.1016/j.athoracsur.2005.02.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
115 Powell AGMT, Hughes DL, Brown J, Larsen M, Witherspoon J, Lewis WG. Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. Diseases of the Esophagus 2017;30:1-8. [DOI: 10.1093/dote/dow039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
116 Ide S, Toiyama Y, Shimura T, Kawamura M, Yasuda H, Saigusa S, Ohi M, Tanaka K, Mohri Y, Kusunoki M. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer. Ann Surg Oncol 2015;22:2585-92. [PMID: 25564164 DOI: 10.1245/s10434-014-4315-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
117 Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, Kakeji Y, Yamanaka T, Maehara Y. Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery. 2008;143:499-508. [PMID: 18374047 DOI: 10.1016/j.surg.2007.12.007] [Cited by in Crossref: 124] [Cited by in F6Publishing: 122] [Article Influence: 8.9] [Reference Citation Analysis]
118 Nakamori M, Iwahashi M, Nakamura M, Yamaue H. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. J Surg Oncol 2003;84:10-6. [PMID: 12949985 DOI: 10.1002/jso.10286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
119 Ilson DH, Minsky BD. CHEMOTHERAPY AND RADIOTHERAPY AS PRIMARY TREATMENT OF ESOPHAGEAL CANCER. Pearson's Thoracic and Esophageal Surgery. Elsevier; 2008. pp. 509-26. [DOI: 10.1016/b978-0-443-06861-4.50198-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Matsuda S, Kawakubo H, Takeuchi H, Hayashi M, Mayanagi S, Takemura R, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma. Br J Surg 2020;107:705-11. [PMID: 32077101 DOI: 10.1002/bjs.11487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
121 Kikuchi H, Endo H, Yamamoto H, Ozawa S, Miyata H, Kakeji Y, Matsubara H, Doki Y, Kitagawa Y, Takeuchi H. Impact of Reconstruction Route on Postoperative Morbidity After Esophagectomy: Analysis of Esophagectomies in the Japanese National Clinical Database. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12501] [Reference Citation Analysis]
122 Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Fukuda H; Japan Clinical Oncology Group. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol. 2003;21:4592-4596. [PMID: 14673047 DOI: 10.1200/jco.2003.12.095] [Cited by in Crossref: 455] [Cited by in F6Publishing: 179] [Article Influence: 25.3] [Reference Citation Analysis]
123 Liu Z, Dong Y, Zhu M, Mu Y, Chen L. Xiaoaiping injection as adjunct therapy for patients with advanced esophageal carcinoma: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20984. [PMID: 32590810 DOI: 10.1097/MD.0000000000020984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Zhang Z, Zhang H. Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer. Dis Esophagus 2017;30:1-7. [PMID: 28375486 DOI: 10.1093/dote/dox002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
125 Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40. [PMID: 28815069 DOI: 10.21037/jtd.2017.03.171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
126 Ikeda Y, Niimi M, Kan S, Takami H, Kodaira S. Thoracoscopic esophagectomy combined with mediastinoscopy via the neck. The Annals of Thoracic Surgery 2002;73:1329-31. [DOI: 10.1016/s0003-4975(01)03593-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
127 Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation. Int J Clin Oncol 2006;11:454-60. [PMID: 17180514 DOI: 10.1007/s10147-006-0610-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
128 Grimminger P, Vallböhmer D, Hoffmann A, Schulte C, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R, Brabender J. Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer. J Surg Oncol. 2009;100:447-451. [PMID: 19653263 DOI: 10.1002/jso.21355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
129 Tanaka T, Fujita H, Matono S, Nagano T, Nishimura K, Murata K, Shirouzu K, Suzuki G, Hayabuchi N, Yamana H. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org). Dis Esophagus 2010;23:646-51. [PMID: 20545979 DOI: 10.1111/j.1442-2050.2010.01069.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
130 Okuyama M, Motoyama S, Suzuki H, Saito R, Maruyama K, Ogawa J. Hand-sewn cervical anastomosis versus stapled intrathoracic anastomosis after esophagectomy for middle or lower thoracic esophageal cancer: a prospective randomized controlled study. Surg Today. 2007;37:947-952. [PMID: 17952523 DOI: 10.1007/s00595-007-3541-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
131 Sandler BJ, Sherwinter D, Panait L, Parent R, Schwartz J, Renton D. SAGES Technology and Value Assessment Committee safety and effectiveness analysis on immunofluorescence in the operating room for biliary visualization and perfusion assessment. Surg Endosc 2017;31:3801-10. [DOI: 10.1007/s00464-017-5638-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
132 Farran L, Miro M, Alba E, Bettonica C, Aranda H, Galan M, Rafecas A. Preoperative gastric conditioning in cervical gastroplasty: Gastric conditioning improve the results in gastroplasty. Diseases of the Esophagus 2011;24:205-10. [DOI: 10.1111/j.1442-2050.2010.01115.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
133 Law S, Wong J. Esophageal cancer: . Current Opinion in Gastroenterology 2001;17:393-9. [DOI: 10.1097/00001574-200107000-00016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Morita M, Otsu H, Kawano H, Kasagi Y, Kimura Y, Saeki H, Ando K, Ida S, Oki E, Tokunaga E, Ikeda T, Kusumoto T, Maehara Y. Gender differences in prognosis after esophagectomy for esophageal cancer. Surg Today 2014;44:505-12. [PMID: 23563736 DOI: 10.1007/s00595-013-0573-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
135 Maruyama K, Motoyama S, Anbai A, Usami S, Sato Y, Shibuya K, Yoshino K, Nakatsu T, Minamiya Y, Ogawa JI. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. Dis Esophagus 2011;24:166-71. [PMID: 20946135 DOI: 10.1111/j.1442-2050.2010.01119.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
136 Zhang H, Li J, Wang YY, Meng AM, Liu Q, Wang L, Chen FH, Wang XC, Zhai ZB, Fu Y, Wang Q. Retinoblastoma 94 enhances radiation treatment of esophageal squamous cell carcinoma in vitro and in vivo. J Radiat Res 2012;53:117-24. [PMID: 22302052 DOI: 10.1269/jrr.11051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
137 Yajima K, Kosugi S, Kanda T, Matsuki A, Hatakeyama K. Risk factors of reflux esophagitis in the cervical remnant following esophagectomy with gastric tube reconstruction. World J Surg 2009;33:284-9. [PMID: 19083053 DOI: 10.1007/s00268-008-9856-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
138 Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700 [PMID: 16237768 DOI: 10.3748/wjg.v11.i36.5696] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
139 Sato Y, Motoyama S, Maruyama K, Okuyama M, Ogawa J. A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement. Journal of the American College of Surgeons 2005;201:188-93. [DOI: 10.1016/j.jamcollsurg.2005.03.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
140 Perry KA, Banarjee A, Liu J, Shah N, Wendling MR, Melvin WS. Gastric ischemic conditioning increases neovascularization and reduces inflammation and fibrosis during gastroesophageal anastomotic healing. Surg Endosc 2013;27:753-60. [DOI: 10.1007/s00464-012-2535-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
141 Henry MA, Lerco MM, de Oliveira WK, Guerra AR, Rodrigues MA. The Glasgow Prognostic Score. An useful tool to predict survival in patients with advanced esophageal squamous cell carcinoma. Acta Cir Bras 2015;30:580-5. [PMID: 26352339 DOI: 10.1590/S0102-8650201500800000010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
142 Yoshida R, Morita M, Shoji F, Nakashima Y, Miura N, Yoshinaga K, Koga T, Tokunaga E, Saeki H, Oki E, Oda Y, Maehara Y. Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2015;22:2608-14. [PMID: 25564163 DOI: 10.1245/s10434-014-4314-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
143 Kawakubo H. Surgery Transthoracic Esophagectomy. In: Ando N, editor. Esophageal Squamous Cell Carcinoma. Singapore: Springer; 2020. pp. 161-75. [DOI: 10.1007/978-981-15-4190-2_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Hashimoto H, Kurata A, Kikuchi H, Masuda Y, Fujita K, Okuyama R, Inoue S, Horiuchi H, Kuroda M. L-type amino acid transporter 1 expression in esophageal carcinogenesis according to WHO and Japanese classifications of intraepithelial neoplasia: LAT1 in esophageal carcinogenesis. Pathol Int 2017;67:247-55. [DOI: 10.1111/pin.12528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
145 Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients. Ann Surg Oncol 2008;15:104-16. [DOI: 10.1245/s10434-007-9604-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
146 Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K, Miyoshi T, Kondo K, Bando Y, Ohnishi Y. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer. 2009;125:952-960. [PMID: 19462449 DOI: 10.1002/ijc.24433] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
147 Wang J, Chang J, Yu H, Wu X, Wang H, Li W, Ji D, Peng W. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus. Cancer Chemother Pharmacol 2013;71:905-11. [DOI: 10.1007/s00280-013-2081-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
148 Kawaguchi Y, Kono K, Mimura K, Mitsui F, Sugai H, Akaike H, Fujii H. Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma. Br J Cancer 2007;97:494-501. [PMID: 17622245 DOI: 10.1038/sj.bjc.6603885] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
149 Lordick F, Ebert M, Stein HJ. Current treatment approach to locally advanced esophageal cancer: is resection mandatory? Future Oncol. 2006;2:717-721. [PMID: 17155898 DOI: 10.2217/14796694.2.6.717] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
150 Booka E, Kikuchi H, Hiramatsu Y, Takeuchi H. The Impact of Infectious Complications after Esophagectomy for Esophageal Cancer on Cancer Prognosis and Treatment Strategy. J Clin Med 2021;10:4614. [PMID: 34640631 DOI: 10.3390/jcm10194614] [Reference Citation Analysis]
151 Uehara H, Miyamoto M, Kato K, Cho Y, Kurokawa T, Murakami S, Fukunaga A, Ebihara Y, Kaneko H, Hashimoto H, Murakami Y, Shichinohe T, Kawarada Y, Itoh T, Okushiba S, Kondo S, Katoh H. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. J Surg Oncol 2005;92:109-15. [DOI: 10.1002/jso.20332] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
152 Yuasa Y, Seike J, Yoshida T, Takechi H, Yamai H, Yamamoto Y, Furukita Y, Goto M, Minato T, Nishino T, Inoue S, Fujiwara S, Tangoku A. Sentinel lymph node biopsy using intraoperative indocyanine green fluorescence imaging navigated with preoperative CT lymphography for superficial esophageal cancer. Ann Surg Oncol 2012;19:486-93. [PMID: 21792510 DOI: 10.1245/s10434-011-1922-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
153 Yang MD, Tsai CW, Chang WS, Tsou YA, Wu CN, Bau DT. Predictive role of XRCC5/XRCC6 genotypes in digestive system cancers. World J Gastrointest Oncol 2011; 3(12): 175-181 [PMID: 22224172 DOI: 10.4251/wjgo.v3.i12.175] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
154 Motoyama S, Ishiyama K, Maruyama K, Narita K, Minamiya Y, Ogawa J. Estimating the need for neck lymphadenectomy in submucosal esophageal cancer using superparamagnetic iron oxide-enhanced magnetic resonance imaging: clinical validation study. World J Surg 2012;36:83-9. [PMID: 22015919 DOI: 10.1007/s00268-011-1322-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
155 Yamashita K, Watanabe M, Mine S, Toihata T, Fukudome I, Okamura A, Yuda M, Hayami M, Ishizuka N, Imamura Y. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Surg Endosc 2018;32:4443-50. [DOI: 10.1007/s00464-018-6187-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
156 Makino T, Yamasaki M, Tanaka K, Wada N, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. The impact of prophylactic administration of a neutrophil elastase inhibitor on the postoperative course in older patients undergoing esophagectomy for esophageal cancer: a propensity score-matched analysis. Esophagus 2017;14:241-8. [DOI: 10.1007/s10388-017-0571-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, Kubochi K, Kitajima M, Matsumoto S. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol. 2007;22:2222-2227. [PMID: 18031385 DOI: 10.1111/j.1440-1746.2006.04736.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 6.2] [Reference Citation Analysis]
158 Schröder W, Hölscher AH, Bludau M, Vallböhmer D, Bollschweiler E, Gutschow C. Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 2010;34:738-43. [PMID: 20098986 DOI: 10.1007/s00268-010-0403-x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
159 Kumakura Y, Rokudai S, Iijima M, Altan B, Yoshida T, Bao H, Yokobori T, Sakai M, Sohda M, Miyazaki T, Nishiyama M, Kuwano H. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma. Cancer Sci 2017;108:2149-55. [PMID: 28892579 DOI: 10.1111/cas.13394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
160 Booka E, Haneda R, Ishii K, Tsushima T, Yasui H, Tsubosa Y. The Negative Impact of Preoperative Chemotherapy on Survival After Esophagectomy for Vulnerable Elderly Patients with Esophageal Cancer. Ann Surg Oncol 2021;28:1786-95. [PMID: 32876790 DOI: 10.1245/s10434-020-09072-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Yang Y, Chu J, Wu Y, Luo M, Xu X, Han Y, Cai Y, Zhan Q, Wang M. Chromosome analysis of esophageal squamous cell carcinoma cell line KYSE 410-4 by repetitive multicolor fluorescence in situ hybridization. J Genet Genomics 2008;35:11-6. [PMID: 18222404 DOI: 10.1016/S1673-8527(08)60002-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
162 Shimada H, Okazumi S, Matsubara H, Shiratori T, Akutsu Y, Nabeya Y, Tanizawa T, Matsushita K, Hayashi H, Isono K, Ochiai T. Long-term Results after Dissection of Positive Thoracic Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma. World J Surg 2008;32:255-61. [DOI: 10.1007/s00268-007-9213-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
163 Booka E, Tsubosa Y, Haneda R, Ishii K. Ability of Laparoscopic Gastric Mobilization to Prevent Pulmonary Complications After Open Thoracotomy or Thoracoscopic Esophagectomy for Esophageal Cancer: A Systematic Review and Meta-analysis. World J Surg 2020;44:980-9. [PMID: 31722075 DOI: 10.1007/s00268-019-05272-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
164 Xu GW, Zheng K, Zhang P. Incidence and causes of postoperative delirium in patients with esophageal cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(11): 1014-1019 [DOI: 10.11569/wcjd.v21.i11.1014] [Reference Citation Analysis]
165 Nakazawa K, Narumi Y, Ishikawa S, Yokoyama K, Nishikage T, Nagai K, Kawano T, Makita K. Effect of prostaglandin E1 on inflammatory responses and gas exchange in patients undergoing surgery for oesophageal cancer. Br J Anaesth. 2004;93:199-203. [PMID: 15169741 DOI: 10.1093/bja/aeh184] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
166 Takeuchi H, Saikawa Y, Oyama T, Ozawa S, Suda K, Wada N, Takahashi T, Nakamura R, Shigematsu N, Ando N, Kitajima M, Kitagawa Y. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg 2010;34:277-84. [PMID: 20033687 DOI: 10.1007/s00268-009-0331-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
167 Takada A, Nakamura T, Takayama K, Makita C, Suzuki M, Azami Y, Kato T, Tsukiyama I, Hareyama M, Kikuchi Y, Daimon T, Toyomasu Y, Ii N, Nomoto Y, Sakuma H, Fuwa N. Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer. Cancer Med 2016;5:506-15. [PMID: 26806272 DOI: 10.1002/cam4.607] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
168 Pöttgen C, Stuschke M. Radiotherapy versus surgery within multimodality protocols for esophageal cancer--a meta-analysis of the randomized trials. Cancer Treat Rev. 2012;38:599-604. [PMID: 22116018 DOI: 10.1016/j.ctrv.2011.10.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
169 Cao X, Li Y, Luo R, He L, Yang J, Zeng M, Wen Z. Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery 2012;93:1674-80. [DOI: 10.1016/j.athoracsur.2011.12.056] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
170 Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis 2017;9:S713-23. [PMID: 28815067 DOI: 10.21037/jtd.2017.07.42] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
171 Kurokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y, Shinohara T, Itoh T, Okushiba S, Kondo S. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer. 2003;89:1042-1047. [PMID: 12966423 DOI: 10.1038/sj.bjc.6601186] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 5.1] [Reference Citation Analysis]
172 Suzuki H, Saito Y, Ikehara H, Oda I. Evaluation of visualization of squamous cell carcinoma of esophagus and pharynx using an autofluorescence imaging videoendoscope system. J Gastroenterol Hepatol. 2009;24:1834-1839. [PMID: 19780882 DOI: 10.1111/j.1440-1746.2009.05941.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
173 Shimada H, Matsubara H, Okazumi S, Isono K, Ochiai T. Improved Surgical Results in Thoracic Esophageal Squamous Cell Carcinoma: A 40-year Analysis of 792 Patients. J Gastrointest Surg 2008;12:518-26. [DOI: 10.1007/s11605-007-0280-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
174 Imamura Y, Hayashi N, Sato N, Kinoshita K, Kurashige J, Saito S, Hirashima K, Karashima R, Hiyoshi Y, Nagai Y, Watanabe M, Baba H. Extensive lymphatic spread of cancer cells in patients with thoracic esophageal squamous cell carcinoma: Detection of CEA-mRNA in the three-field lymph nodes: Lymphatic Spread of Esophageal Cancer. J Surg Oncol 2010;102:509-15. [DOI: 10.1002/jso.21621] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
175 Takeuchi H, Kawakubo H, Kitagawa Y. Current status of minimally invasive esophagectomy for patients with esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:513-521. [PMID: 23661109 DOI: 10.1007/s11748-013-0258-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
176 Kaburagi T, Takeuchi H, Fujii H, Saikawa Y, Murakami K, Fukada J, Shigematsu N, Ozawa S, Ando N, Kitagawa Y. Initial experience of individualized chemoradiotherapy for superficial esophageal cancers based on the sentinel lymph node concept. Esophagus 2012;9:147-52. [DOI: 10.1007/s10388-012-0317-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
177 Takeno S, Takahashi Y, Moroga T, Kawahara K, Yamashita Y, Ohtaki M. Retrospective study using the propensity score to clarify the oncologic feasibility of thoracoscopic esophagectomy in patients with esophageal cancer. World J Surg 2013;37:1673-80. [PMID: 23539192 DOI: 10.1007/s00268-013-2008-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
178 Oshikiri T, Takiguchi G, Miura S, Goto H, Otsubo D, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Fujino Y, Tominaga M, Nakamura T, Suzuki S, Kakeji Y. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study. Ann Surg Oncol 2019;26:4053-61. [PMID: 31313045 DOI: 10.1245/s10434-019-07627-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
179 Kato H, Arao T, Matsumoto K, Fujita Y, Kimura H, Hayashi H, Nishiki K, Iwama M, Shiraishi O, Yasuda A. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma. Int J Oncol. 2013;42:1151-1158. [PMID: 23426935 DOI: 10.3892/ijo.2013.1830] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
180 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109. [PMID: 15701501 DOI: 10.1016/j.amjsurg.2004.10.001] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 6.9] [Reference Citation Analysis]
181 Tobari S, Ikeda Y, Takami H. Beneficial Effects of Intravenous Administration of Lipo-Prostaglandin E1 on the Ischemic Gastric Tube in Pigs. Journal of Surgical Research 2005;129:79-84. [DOI: 10.1016/j.jss.2005.05.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
182 Xu JQ, Hu JW, Chen WF, Xu MD, Zhong YS, Chen SY, Zhang YQ, Ma LL, Qin WZ, Cai MY, Yao LQ, Zhou PH, Li QL. Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy. Surg Endosc 2021;35:2229-39. [PMID: 32430528 DOI: 10.1007/s00464-020-07636-y] [Reference Citation Analysis]
183 Li J, Tang Y, Huang L, Yu Q, Hu G, Zou Y, Yuan X. A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma. Dis Esophagus 2017;30:1-7. [PMID: 27868286 DOI: 10.1111/dote.12518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
184 Wada S, Noguchi T, Takeno S, Kawahara K. PIK3CA and TFRC Located in 3q Are New Prognostic Factors in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2006;13:961-6. [DOI: 10.1245/aso.2006.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
185 Ebihara Y, Miyamoto M, Fukunaga A, Kato K, Shichinohe T, Kawarada Y, Kurokawa T, Cho Y, Murakami S, Uehara H, Kaneko H, Hashimoto H, Murakami Y, Itoh T, Okushiba S, Kondo S, Katoh H. DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma. Br J Cancer 2004;91:119-23. [PMID: 15188007 DOI: 10.1038/sj.bjc.6601899] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
186 Shen Y, Zhang Y, Tan L, Feng M, Wang H, Khan MA, Liang M, Wang Q. Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center. J Gastrointest Surg 2012;16:715-21. [PMID: 22258878 DOI: 10.1007/s11605-012-1824-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
187 Hayashi K, Motoyama S, Koyota S, Koizumi Y, Wang J, Takasawa S, Itaya-Hironaka A, Sakuramoto-Tsuchida S, Maruyama K, Saito H, Minamiya Y, Ogawa J, Sugiyama T. REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci 2008;99:2491-5. [PMID: 19032369 DOI: 10.1111/j.1349-7006.2008.00980.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
188 Farran Teixidor L, Miró Martín M, Bettónica Larrañaga C, Aranda Danso H. [Dehiscence in cervical gastroplasty: is it possible to reduce its incidence?]. Cir Esp 2008;84:237; author reply 237-8. [PMID: 18928782 DOI: 10.1016/s0009-739x(08)72631-9] [Reference Citation Analysis]
189 Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Sugihara K, Mori M. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259-266. [PMID: 24743609 DOI: 10.1097/sla.0000000000000644] [Cited by in Crossref: 275] [Cited by in F6Publishing: 111] [Article Influence: 39.3] [Reference Citation Analysis]
190 Matsuda S, Takeuchi H, Kawakubo H, Ando N, Kitagawa Y. Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan. Ann Thorac Cardiovasc Surg 2016;22:275-83. [PMID: 27384595 DOI: 10.5761/atcs.ra.16-00111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
191 Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, Nonaka T, Ishikawa H, Katoh H, Takahashi T, Nakano T. Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 2011;80:1002-7. [PMID: 20542385 DOI: 10.1016/j.ijrobp.2010.03.046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
192 Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg. 2004;78:1177-1183. [PMID: 15464466 DOI: 10.1016/j.athoracsur.2004.02.068] [Cited by in Crossref: 103] [Cited by in F6Publishing: 95] [Article Influence: 6.1] [Reference Citation Analysis]
193 Wang S, Tachimori Y, Hokamura N, Igaki H, Kishino T, Kushima R. Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: a single-center experience. Ann Thorac Surg 2013;96:1002-6. [PMID: 23810175 DOI: 10.1016/j.athoracsur.2013.04.072] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
194 Kikuchi S, Kishimoto H, Tazawa H, Hashimoto Y, Kuroda S, Nishizaki M, Nagasaka T, Shirakawa Y, Kagawa S, Urata Y, Hoffman RM, Fujiwara T. Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer. Mol Ther 2015;23:501-9. [PMID: 25523761 DOI: 10.1038/mt.2014.244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
195 Itami A, Watanabe G, Tanaka E, Nakayama S, Fujimoto A, Kondo M, Nakau M, Okabe H, Satoh S, Sakai Y. Upper mediastinal lymph node dissection for esophageal cancer through a thoracoscopic approach. Surg Endosc 2008;22:2741-2741. [DOI: 10.1007/s00464-008-0106-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
196 Li XK, Hua TT, Zhang C, Xu Y, Wu WJ, Zheng C, Wang GM, Qiang Y, Cong ZZ, Yi J, Shen Y. The ratio of gastric tube length to thorax length: a vital factor affecting leak after esophageal cervical anastomosis. Ann Transl Med 2021;9:458. [PMID: 33850855 DOI: 10.21037/atm-20-6082] [Reference Citation Analysis]
197 Takeuchi H, Ikeuchi S, Kawaguchi Y, Kitagawa Y, Isobe Y, Kubochi K, Kitajima M, Matsumoto S. Clinical Significance of Perioperative Immunonutrition for Patients with Esophageal Cancer. World J Surg 2007;31:2160-7. [DOI: 10.1007/s00268-007-9219-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
198 Zheng X, Zhao Y, Wang X, Li Y, Wang R, Jiang Y, Gong T, Li M, Sun L, Hong L. Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Dig Dis Sci. 2010;55:3408-3414. [PMID: 20411424 DOI: 10.1007/s10620-010-1212-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
199 Tong DK, Law S. Management of oesophageal cancer. Indian J Surg 2009;71:317-25. [PMID: 23133184 DOI: 10.1007/s12262-009-0087-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
200 Baba Y, Watanabe M, Yoshida N, Baba H. Neoadjuvant treatment for esophageal squamous cell carcinoma. World J Gastrointest Oncol 2014; 6(5): 121-128 [PMID: 24834142 DOI: 10.4251/wjgo.v6.i5.121] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
201 Bai Y, Lin H, Fang Z, Luo Q, Fang Y, Su Y, Hu Q, Duan H, Chen F, Zhang ZY. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis. Biomark Med 2017;11:431-41. [PMID: 28621611 DOI: 10.2217/bmm-2016-0286] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
202 Nakakubo Y, Hida Y, Miyamoto M, Hashida H, Oshikiri T, Kato K, Suzuoki M, Hiraoka K, Ito T, Morikawa T, Okushiba S, Kondo S, Katoh H. The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Letters 2002;177:101-5. [DOI: 10.1016/s0304-3835(01)00773-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
203 Kernstine KH, DeArmond DT, Shamoun DM, Campos JH. The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience. Surg Endosc. 2007;21:2285-2292. [PMID: 17593457 DOI: 10.1007/s00464-007-9405-7] [Cited by in Crossref: 90] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
204 Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, Imai K, Maeda E, Minamiya Y. IGF2BP3 Expression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma. J Surg Res 2021;259:137-44. [PMID: 33279839 DOI: 10.1016/j.jss.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
205 Yoshimura S, Takahashi M, Aikou S, Okumura Y, Jinbo K, Onoyama H, Urabe M, Kawasaki K, Yagi K, Nishida M, Mori K, Yamashita H, Nomura S, Koyama K, Momose T, Abe H, Ushiku T, Fukayama M, Seto Y. One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer. Clin Nucl Med 2020;45:741-6. [PMID: 32796247 DOI: 10.1097/RLU.0000000000003224] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Kobayashi M, Koh M, Irinoda T, Meguro E, Hayakawa Y, Takagane A. Stroke volume variation as a predictor of intravascular volume depression and possible hypotension during the early postoperative period after esophagectomy. Ann Surg Oncol 2009;16:1371-7. [PMID: 19219508 DOI: 10.1245/s10434-008-0139-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
207 Shimada Y, Okumura T, Nagata T, Sawada S, Matsui K, Hori R, Yoshioka I, Yoshida T, Osada R, Tsukada K. Usefulness of blood supply visualization by indocyanine green fluorescence for reconstruction during esophagectomy. Esophagus. 2011;8:259-266. [PMID: 22557942 DOI: 10.1007/s10388-011-0291-7] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
208 Hirano Y, Onozawa M, Hojo H, Motegi A, Zenda S, Hotta K, Moriya S, Tachibana H, Nakamura N, Kojima T, Akimoto T. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. Radiat Oncol 2018;13:23. [PMID: 29426342 DOI: 10.1186/s13014-018-0966-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
209 Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H. CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2009;16:506-14. [DOI: 10.1245/s10434-008-0252-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
210 Ma H, Li Y, Ding Z, Liu X, Xu J, Qin J. The clinical significance of subcarinal lymph node dissection in the radical resection of oesophageal cancer. Interact Cardiovasc Thorac Surg 2013;16:839-43. [PMID: 23475120 DOI: 10.1093/icvts/ivt070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
211 Feng J, Xu Y, Wei Z, Xia Y, Zhang H, Shen C, Wang P, Yan W, Fang D, Fang Y. Capsaicin inhibits migration and invasion via inhibiting epithelial-mesenchymal transition in esophageal squamous cell carcinoma by up-regulation of claudin-3 expression. Journal of Functional Foods 2022;89:104934. [DOI: 10.1016/j.jff.2022.104934] [Reference Citation Analysis]
212 Xu J, Lu D, Zhang L, Li J, Sun G. Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer. Cancer Med 2019;8:7253-64. [PMID: 31612596 DOI: 10.1002/cam4.2609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
213 Kuwabara S, Ebihara Y, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S. Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: a case report. BMC Surg 2017;17:122. [PMID: 29197361 DOI: 10.1186/s12893-017-0326-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
214 Jang HJ, Lee HS, Kim MS, Lee JM, Zo JI. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma. Ann Thorac Surg 2011;92:1091-7. [PMID: 21704967 DOI: 10.1016/j.athoracsur.2011.03.093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
215 Yuasa N, Sasaki E, Ikeyama T, Miyake H, Nimura Y. Acid and duodenogastroesophageal reflux after esophagectomy with gastric tube reconstruction. Am J Gastroenterol. 2005;100:1021-1027. [PMID: 15842574 DOI: 10.1111/j.1572-0241.2005.41109.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
216 Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, Watanabe H, Maruyama K, Okuyama M, Ogawa J. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Ann Surg Oncol. 2006;13:1724-1731. [PMID: 17009160 DOI: 10.1245/s10434-006-9075-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
217 Stippel DL, Taylan C, Schröder W, Beckurts KTE, Hölscher AH. Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. Diseases of the Esophagus 2005;18:267-73. [DOI: 10.1111/j.1442-2050.2005.00487.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
218 Ikeguchi M, Kouno Y, Kihara K, Suzuki K, Endo K, Nakamura S, Sawada T, Shimizu T, Matsunaga T, Fukumoto Y, Saito H. Evaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomas. Mol Clin Oncol 2016;5:767-72. [PMID: 28105355 DOI: 10.3892/mco.2016.1073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
219 Yin Z, Cai H, Wang Z, Jiang Y. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147. Drug Des Devel Ther 2020;14:4561-73. [PMID: 33149553 DOI: 10.2147/DDDT.S269915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Mega S, Miyamoto M, Ebihara Y, Takahashi R, Hase R, Li L, Shichinohe T, Kawarada Y, Uehara H, Kaneko H. Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma. Dis Esophagus. 2005;18:109-113. [PMID: 16053486 DOI: 10.1111/j.1442-2050.2005.00463.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
221 Kawakubo H, Takeuchi H, Kitagawa Y. Current status and future perspectives on minimally invasive esophagectomy. Korean J Thorac Cardiovasc Surg. 2013;46:241-248. [PMID: 24003404 DOI: 10.5090/kjtcs.2013.46.4.241] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
222 Nabeya Y, Ochiai T, Matsubara H, Okazumi S, Shiratori T, Shuto K, Aoki T, Miyazaki S, Gunji Y, Uno T, Ito H, Shimada H. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Diseases of the Esophagus 2005;18:388-97. [DOI: 10.1111/j.1442-2050.2005.00521.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
223 Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, Imai K, Minamiya Y. Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer. Ann Surg Oncol 2021;28:2101-10. [PMID: 33051740 DOI: 10.1245/s10434-020-09206-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Del Genio A, Rossetti G, Napolitano V, Maffettone V, Renzi A, Brusciano L, Russo G, Del Genio G. Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy. Surg Endosc 2004;18:1789-94. [DOI: 10.1007/s00464-003-9243-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
225 Hölscher AH, Vallböhmer D, Brabender J. The prevention and management of perioperative complications. Best Pract Res Clin Gastroenterol. 2006;20:907-923. [PMID: 16997169 DOI: 10.1016/j.bpg.2006.05.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
226 Zhao Y, Hong L, Wang R, Fan D. Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma. Dig Dis Sci. 2009;54:586-592. [PMID: 18594968 DOI: 10.1007/s10620-008-0380-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
227 Mitani S, Kadowaki S, Oze I, Masuishi T, Narita Y, Bando H, Oonishi S, Hirayama Y, Tanaka T, Tajika M, Koide Y, Kodaira T, Abe T, Muro K. Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis. Cancer Med 2020;9:394-400. [PMID: 31730285 DOI: 10.1002/cam4.2688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
228 Lv Y, Zhang J, Qiao L. Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy. Mol Clin Oncol 2014;2:870-4. [PMID: 25054060 DOI: 10.3892/mco.2014.313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
229 Cao X, Zhong JD, Yang TZ, Jiang YC, Wen ZS. Do male esophageal cancer patients have impaired sexual function after esophagectomy? A self-reported outcomes study. Qual Life Res 2017;26:3331-41. [PMID: 28766083 DOI: 10.1007/s11136-017-1677-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
230 Motoyama S, Saito R, Okuyama M, Maruyama K, Nanjo H, Ogawa J. Long-term survival after salvage resection of recurrent esophageal cancer with anterior mediastinal lymph node involvement: report of a case. Surg Today 2006;36:827-30. [PMID: 16937289 DOI: 10.1007/s00595-006-3242-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
231 Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Hara J, Yamamura T, Inoue M. Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma. Mol Clin Oncol 2013;1:773-9. [PMID: 24649245 DOI: 10.3892/mco.2013.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
232 Ferri LE, Law S, Wong K, Kwok K, Wong J. The Influence of Technical Complications on Postoperative Outcome and Survival After Esophagectomy. Ann Surg Oncol 2006;13:557-64. [DOI: 10.1245/aso.2006.04.040] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
233 Kawaguchi Y, Kono K, Mimura K, Sugai H, Akaike H, Fujii H. Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma. Int J Cancer. 2007;120:781-787. [PMID: 17096332 DOI: 10.1002/ijc.22370] [Cited by in Crossref: 122] [Cited by in F6Publishing: 106] [Article Influence: 8.1] [Reference Citation Analysis]
234 Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S. Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample. Surg Endosc. 2017;31:2491-2497. [PMID: 27660245 DOI: 10.1007/s00464-016-5251-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
235 Booka E, Takeuchi H, Kikuchi H, Hiramatsu Y, Kamiya K, Kawakubo H, Kitagawa Y. Recent advances in thoracoscopic esophagectomy for esophageal cancer: Thoracoscopic esophagectomy. Asian J Endosc Surg 2019;12:19-29. [DOI: 10.1111/ases.12681] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
236 Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y, Koyota S. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol. 2008;15:1224-1231. [PMID: 18259819 DOI: 10.1245/s10434-008-9810-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
237 Chai T, Shen Z, Zhang P, Lin Y, Chen S, Zhang Z, Lin W, Kang M, Lin J. Postoperative adjuvant therapy for resectable esophageal cancer: A protocol of a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e15485. [PMID: 31096448 DOI: 10.1097/MD.0000000000015485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
238 Pasquier D, Mirabel X, Adenis A, Rezvoy N, Hecquet G, Fournier C, Coche-Dequeant B, Prevost B, Castelain B, Lartigau E. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys 2006;65:1456-61. [PMID: 16863928 DOI: 10.1016/j.ijrobp.2006.02.049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
239 Korn WM. Prevention and management of early esophageal cancer. Curr Treat Options Oncol. 2004;5:405-416. [PMID: 15341678 DOI: 10.1007/s11864-004-0030-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
240 Herbella FAM, Laurino Neto RM, Allaix ME, Patti MG. Extended Lymphadenectomy in Esophageal Cancer is Debatable. World J Surg 2013;37:1757-67. [DOI: 10.1007/s00268-013-2018-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
241 Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, Mitsuhashi N. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol 2008;15:2451-7. [PMID: 18592318 DOI: 10.1245/s10434-008-0016-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
242 Lee K, Kim JH, Han S, Sung C, Do I, Ko Y, Um SH, Kim S. Twist1 Is an Independent Prognostic Factor of Esophageal Squamous Cell Carcinoma and Associated with Its Epithelial–Mesenchymal Transition. Ann Surg Oncol 2012;19:326-35. [DOI: 10.1245/s10434-011-1867-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
243 Qian J, Tong Z, Zhang Y, Chen C. Platinum versus immunotherapy for unresectable esophageal cancer: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e23537. [PMID: 33371077 DOI: 10.1097/MD.0000000000023537] [Reference Citation Analysis]
244 Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360-7; discussion 368. [PMID: 11524589 DOI: 10.1097/00000658-200109000-00010] [Cited by in Crossref: 367] [Cited by in F6Publishing: 320] [Article Influence: 17.5] [Reference Citation Analysis]
245 Duan J, Deng T, Ying G, Huang D, Zhang H, Zhou L, Bai M, Li H, Yang H, Qu Y, Wang X, Ba Y. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy. Jpn J Clin Oncol 2016;46:336-43. [PMID: 26819278 DOI: 10.1093/jjco/hyv206] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
246 Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538-543. [PMID: 12781882 DOI: 10.1016/s0002-9610(03)00066-7] [Cited by in Crossref: 460] [Cited by in F6Publishing: 138] [Article Influence: 24.2] [Reference Citation Analysis]
247 Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil vs preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68-74. [PMID: 21879261 DOI: 10.1245/s10434-011-2049-9] [Cited by in Crossref: 647] [Cited by in F6Publishing: 597] [Article Influence: 58.8] [Reference Citation Analysis]
248 Niwa Y, Yamada S, Koike M, Kanda M, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y. Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2014;110:764-769. [PMID: 24975035 DOI: 10.1002/jso.23694] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
249 Sakurai Y, Masui T, Yoshida I, Tonomura S, Shoji M, Nakamura Y, Isogaki J, Uyama I, Komori Y, Ochiai M. Randomized Clinical Trial of the Effects of Perioperative Use of Immune-enhancing Enteral Formula on Metabolic and Immunological Status in Patients Undergoing Esophagectomy. World J Surg 2007;31:2150-7. [DOI: 10.1007/s00268-007-9170-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
250 Morita M, Maehara Y. Esophagus Carcinoma Surveillance Counterpoint: Japan. In: Johnson FE, Maehara Y, Browman GP, Margenthaler JA, Audisio RA, Thompson JF, Johnson DY, Earle CC, Virgo KS, editors. Patient Surveillance After Cancer Treatment. Totowa: Humana Press; 2013. pp. 101-5. [DOI: 10.1007/978-1-60327-969-7_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
251 Lordick F, Ott K, Novotny A, Schuhmacher C, Siewert J. R1-Resektion in der Chirurgie des oberen Gastrointestinaltrakts: Bedeutung und therapeutische Konsequenzen. Chirurg 2007;78:792-801. [DOI: 10.1007/s00104-007-1381-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
252 Schröder W, Gutschow CA, Hölscher AH. Limited resection for early esophageal cancer? Langenbecks Arch Surg 2003;388:88-94. [DOI: 10.1007/s00423-003-0371-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
253 Booka E, Nakano Y, Mihara K, Nishiya S, Nishiyama R, Shibutani S, Sato T, Egawa T. The impact of epidural catheter insertion level on pain control after esophagectomy for esophageal cancer. Esophagus 2020;17:175-82. [DOI: 10.1007/s10388-019-00682-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
254 Oshikiri T, Takiguchi G, Miura S, Takase N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda Y, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. Non-placement versus placement of a drainage tube around the cervical anastomosis in McKeown esophagectomy: study protocol for a randomized controlled trial. Trials 2019;20:758. [PMID: 31870427 DOI: 10.1186/s13063-019-3750-4] [Reference Citation Analysis]
255 Nagaraja V, Eslick GD, Cox MR. Sentinel lymph node in oesophageal cancer-a systematic review and meta-analysis. J Gastrointest Oncol 2014;5:127-41. [PMID: 24772341 DOI: 10.3978/j.issn.2078-6891.2014.008] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
256 Perry KA, Enestvedt CK, Pham TH, Dolan JP, Hunter JG. Esophageal Replacement Following Gastric Devascularization Is Safe, Feasible, and May Decrease Anastomotic Complications. J Gastrointest Surg 2010;14:1069-73. [DOI: 10.1007/s11605-010-1204-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
257 Takesue T, Takeuchi H, Fukuda K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y. Postoperative Hyperbilirubinemia Suggests the Occurrence of Complications After Esophagectomy for Esophageal Cancer. World J Surg 2015;39:1111-8. [DOI: 10.1007/s00268-014-2936-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
258 Kinugasa S, Tachibana M, Yoshimura H, Ueda S, Fujii T, Dhar DK, Nakamoto T, Nagasue N. Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy. J Surg Oncol. 2004;88:71-77. [PMID: 15499604 DOI: 10.1002/jso.20137] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 5.3] [Reference Citation Analysis]
259 Toh Y, Kitagawa Y, Kuwano H, Kusano M, Oyama T, Muto M, Kato H, Takeuchi H, Doki Y, Naomoto Y, Nemoto K, Matsubara H, Miyazaki T, Yanagisawa A, Uno T, Kato K, Yoshida M, Kawakubo H, Booka E. A nation-wide survey of follow-up strategies for esophageal cancer patients after a curative esophagectomy or a complete response by definitive chemoradiotherapy in Japan. Esophagus 2016;13:173-81. [DOI: 10.1007/s10388-015-0511-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
260 Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002;9:807-11. [PMID: 12374665 DOI: 10.1007/BF02574504] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
261 Ishige F, Nabeya Y, Hoshino I, Takayama W, Chiba S, Arimitsu H, Iwatate Y, Yanagibashi H. Quantitative Assessment of the Blood Perfusion of the Gastric Conduit by Indocyanine Green Imaging. Journal of Surgical Research 2019;234:303-10. [DOI: 10.1016/j.jss.2018.08.056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
262 Yamamoto Y, Yamai H, Seike J, Yoshida T, Takechi H, Furukita Y, Kajiura K, Minato T, Bando Y, Tangoku A. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin. Ann Surg Oncol. 2012;19:757-765. [PMID: 21947696 DOI: 10.1245/s10434-011-2071-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
263 Okuyama M, Motoyama S, Maruyama K, Sasaki K, Sato Y, Ogawa J. Proton Pump Inhibitors Relieve and Prevent Symptoms Related to Gastric Acidity after Esophagectomy. World J Surg 2008;32:246-54. [DOI: 10.1007/s00268-007-9325-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
264 Makino H, Kunisaki C, Kosaka T, Akiyama H, Morita S, Endo I. Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer. Br J Surg. 2011;98:975-982. [PMID: 21557207 DOI: 10.1002/bjs.7499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
265 Takala H, Saarnio J, Wiik H, Soini Y. Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. Apmis 2007;115:838-47. [DOI: 10.1111/j.1600-0463.2007.apm_656.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
266 Benzoni E, Bresadola V, Terrosu G, Uzzau A, Cedolini C, Intini S, Noce L, Bresadola F. Minimally invasive esophagectomy: a comparative study of transhiatal laparoscopic approach versus laparoscopic right transthoracic esophagectomy. Surg Laparosc Endosc Percutan Tech 2008;18:178-87. [PMID: 18427338 DOI: 10.1097/SLE.0b013e318165f205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
267 Zhang J, Peng F, Li N, Liu Y, Xu Y, Zhou L, Wang J, Zhu J, Huang M, Gong Y. Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer. Radiat Oncol. 2012;7:93. [PMID: 22713587 DOI: 10.1186/1748-717x-7-93] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
268 Takizawa K, Matsuda T, Kozu T, Eguchi T, Kato H, Nakanishi Y, Hijikata A, Saito D. Lymph node staging in esophageal squamous cell carcinoma: A comparative study of endoscopic ultrasonography versus computed tomography. Journal of Gastroenterology and Hepatology 2009;24:1687-91. [DOI: 10.1111/j.1440-1746.2009.05927.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
269 Bludau M, Vallböhmer D, Gutschow C, Hölscher AH, Schröder W. Quantitative measurement of gastric mucosal microcirculation using a combined laser Doppler flowmeter and spectrophotometer. Dis Esophagus 2008;21:668-72. [PMID: 18564159 DOI: 10.1111/j.1442-2050.2008.00856.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
270 Suzuki H, Saito Y, Oda I, Kikuchi T, Kiriyama S, Fukunaga S. Comparison of narrowband imaging with autofluorescence imaging for endoscopic visualization of superficial squamous cell carcinoma lesions of the esophagus. Diagn Ther Endosc 2012;2012:507597. [PMID: 23197931 DOI: 10.1155/2012/507597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
271 Emi M, Hihara J, Hamai Y, Furukawa T, Ibuki Y, Okada M. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2017;104:1858-64. [PMID: 29033014 DOI: 10.1016/j.athoracsur.2017.06.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
272 Liu Q, Qiu Y, Deng X, Min J, Dai J. Comparison of outcomes following end-to-end hand-sewn and mechanical oesophagogastric anastomosis after oesophagectomy for carcinoma: a prospective randomized controlled trial. European Journal of Cardio-Thoracic Surgery 2015;47:e118-23. [DOI: 10.1093/ejcts/ezu457] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
273 Jiao WJ, Wang TY, Gong M, Pan H, Liu YB, Liu ZH. Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy. World J Gastroenterol 2006; 12(16): 2505-2509 [PMID: 16688794 DOI: 10.3748/wjg.v12.i16.2505] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
274 Hölscher AH, Schneider PM, Gutschow C, Schröder W. Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007;245:241-6. [PMID: 17245177 DOI: 10.1097/01.sla.0000245847.40779.10] [Cited by in Crossref: 157] [Cited by in F6Publishing: 134] [Article Influence: 10.5] [Reference Citation Analysis]
275 Halliday BP, Skipworth RJ, Wall L, Phillips HA, Couper GW, de Beaux AC, Paterson-Brown S. Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience. Int Semin Surg Oncol 2007;4:24. [PMID: 17937823 DOI: 10.1186/1477-7800-4-24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
276 Yetasook AK, Leung D, Howington JA, Talamonti MS, Zhao J, Carbray JM, Ujiki MB. Laparoscopic ischemic conditioning of the stomach prior to esophagectomy: Laparoscopic ischemic conditioning. Diseases of the Esophagus 2013;26:479-86. [DOI: 10.1111/j.1442-2050.2012.01374.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
277 Satomi T, Kawano S, Inaba T, Nakagawa M, Mouri H, Yoshioka M, Tanaka S, Toyokawa T, Kobayashi S, Tanaka T, Kanzaki H, Iwamuro M, Kawahara Y, Okada H. Efficacy and safety of endoscopic submucosal dissection for gastric tube cancer: A multicenter retrospective study. World J Gastroenterol 2021; 27(11): 1043-1054 [PMID: 33776371 DOI: 10.3748/wjg.v27.i11.1043] [Reference Citation Analysis]
278 Mohiuddin K, Low DE. Functional Conduit Disorder Complicating Esophagectomy. Thoracic Surgery Clinics 2015;25:471-83. [DOI: 10.1016/j.thorsurg.2015.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
279 Takeuchi H, Kitagawa Y. Sentinel node navigation surgery in esophageal cancer. Ann Gastroenterol Surg 2019;3:7-13. [PMID: 30697605 DOI: 10.1002/ags3.12206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
280 Quan YH, Kim M, Kim HK, Kim BM. Fluorescent image-based evaluation of gastric conduit perfusion in a preclinical ischemia model. J Thorac Dis 2018;10:5359-67. [PMID: 30416783 DOI: 10.21037/jtd.2018.08.46] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
281 Berkelmans GH, van Workum F, Weijs TJ, Nieuwenhuijzen GA, Ruurda JP, Kouwenhoven EA, van Det MJ, Rosman C, van Hillegersberg R, Luyer MD. The feeding route after esophagectomy: a review of literature. J Thorac Dis. 2017;9:S785-S791. [PMID: 28815075 DOI: 10.21037/jtd.2017.03.152] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
282 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y. Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 2011;59:461-6. [PMID: 21751104 DOI: 10.1007/s11748-011-0780-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
283 Vallböhmer D, Kuhn E, Warnecke-eberz U, Brabender J, Hoffmann AC, Metzger R, Baldus SE, Drebber U, Hoelscher AH, Schneider PM. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 2008;9:681-90. [DOI: 10.2217/14622416.9.6.681] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
284 Law S. Esophagectomy without mortality: what can surgeons do? J Gastrointest Surg 2010;14 Suppl 1:S101-7. [PMID: 19774427 DOI: 10.1007/s11605-009-1028-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
285 Wada T, Takeuchi H, Kawakubo H, Nakamura R, Oyama T, Takahashi T, Wada N, Saikawa Y, Omori T, Jinzaki M, Kuribayashi S, Kitagawa Y. Clinical utility of preoperative evaluation of bronchial arteries by three-dimensional computed tomographic angiography for esophageal cancer surgery. Dis Esophagus 2013;26:616-22. [PMID: 23237474 DOI: 10.1111/dote.12012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
286 Dhar DK, Tachibana M, Kinukawa N, Riruke M, Kohno H, Little AG, Nagasue N. The prognostic significance of lymph node size in patients with squamous esophageal cancer. Annals of Surgical Oncology 2002;9:1010-6. [DOI: 10.1007/bf02574521] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
287 Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, Akiyama Y, Ishida K, Saito K, Endo S. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184-190. [PMID: 12170023 DOI: 10.1097/00000658-200208000-00006] [Cited by in Crossref: 130] [Cited by in F6Publishing: 117] [Article Influence: 6.5] [Reference Citation Analysis]
288 Rosso KJ, Nathanson SD. Techniques that accurately identify the sentinel lymph node in cancer. World J Surg Proced 2015; 5(1): 14-26 [DOI: 10.5412/wjsp.v5.i1.14] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
289 Nagata M, Yamamoto H, Takiguchi N, Kainuma O, Cho A, Mori M, Narumoto S, Asano T, Hatano K. Neoadjuvant chemoradiotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma. Esophagus 2006;3:105-11. [DOI: 10.1007/s10388-006-0081-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
290 Nishi T, Takeuchi H, Matsuda S, Ogura M, Kawakubo H, Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, Kitagawa Y. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer. World J Surg Oncol 2015;13:232. [PMID: 26231560 DOI: 10.1186/s12957-015-0658-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
291 Takeuchi H, Fujii H, Ando N, Ozawa S, Saikawa Y, Suda K, Oyama T, Mukai M, Nakahara T, Kubo A, Kitajima M, Kitagawa Y. Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 2009;249:757-63. [PMID: 19387329 DOI: 10.1097/SLA.0b013e3181a38e89] [Cited by in Crossref: 77] [Cited by in F6Publishing: 26] [Article Influence: 5.9] [Reference Citation Analysis]
292 Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684-692. [PMID: 16244542 DOI: 10.1097/01.sla.0000186170.38348.7b] [Cited by in Crossref: 256] [Cited by in F6Publishing: 242] [Article Influence: 15.1] [Reference Citation Analysis]
293 Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20:478-486. [PMID: 17958722 DOI: 10.1111/j.1442-2050.2007.00699.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
294 Lundell L. Re: “DRD2/DARPP-32 Expression Correlates with Lymph Node Metastasis and Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma”. World J Surg 2006;30:1680-1. [DOI: 10.1007/s00268-006-0338-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
295 Toh Y, Oki E, Minami K, Okamura T. Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer: the first indicators for recurrence and their prognostic values. Esophagus 2010;7:37-43. [DOI: 10.1007/s10388-009-0221-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
296 Filip B, Scarpa M, Cavallin F, Alfieri R, Cagol M, Castoro C. Minimally invasive surgery for esophageal cancer: a review on sentinel node concept. Surg Endosc. 2014;28:1238-1249. [PMID: 24281431 DOI: 10.1007/s00464-013-3314-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
297 Nozoe T, Kakeji Y, Baba H, Maehara Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus. 2005;18:226-229. [PMID: 16128778 DOI: 10.1111/j.1442-2050.2005.00482.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
298 Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005;103:1347-1355. [PMID: 15719440 DOI: 10.1002/cncr.20916] [Cited by in Crossref: 279] [Cited by in F6Publishing: 282] [Article Influence: 16.4] [Reference Citation Analysis]
299 Motoyama S, Kitamura M, Saito R, Maruyama K, Okuyama M, Ogawa J. Outcome and Treatment Strategy for Mid- and Lower-Thoracic Esophageal Cancer Recurring Locally in the Lymph Nodes of the Neck. World J Surg 2006;30:191-8. [DOI: 10.1007/s00268-005-0092-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
300 Shoji Y, Takeuchi H, Fukuda K, Nakamura R, Wada N, Kawakubo H, Kitagawa Y. Air Bubble Sign: A New Screening Method for Anastomotic Leakage After Esophagectomy for Esophageal Cancer. Ann Surg Oncol 2018;25:1061-8. [PMID: 29318416 DOI: 10.1245/s10434-017-6327-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
301 Vallbohmer D, Oh DS, Peters JH. The role of lymphadenectomy in the surgical treatment of esophageal and gastric cancer. Curr Probl Surg 2012;49:471-515. [PMID: 22793506 DOI: 10.1067/j.cpsurg.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
302 Kato K, Nakajima TE, Ito Y, Katada C, Ishiyama H, Tokunaga SY, Tanaka M, Hironaka S, Hashimoto T, Ura T, Kodaira T, Yoshimura K. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma. Jpn J Clin Oncol 2013;43:608-15. [PMID: 23585687 DOI: 10.1093/jjco/hyt048] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
303 Onodera Y, Taniyama Y, Sakurai T, Hikage M, Sato C, Takaya K, Okamoto H, Maruyama S, Konno T, Unno M, Kamei T. Thoracoscopic esophagectomy with subcarinal lymph node dissection in the prone position for esophageal cancer with a right superior pulmonary vein anomaly: a case report. Surg Case Rep 2019;5:6. [PMID: 30644002 DOI: 10.1186/s40792-019-0567-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
304 Kim HS, Lee SE, Bae YS, Kim DJ, Lee CG, Hur J, Chung H, Park JC, Jung DH, Shin SK, Lee SK, Lee YC, Kim HR, Moon YW, Kim JH, Shim YM, Jewell SS, Kim H, Choi YL, Cho BC. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. Oncotarget 2015;6:2562-72. [PMID: 25537505 DOI: 10.18632/oncotarget.2944] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
305 Wang J, Liu M, Shen J, Ouyang H, Xie X, Lin T, Li A, Yang H. Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer. BMC Cancer 2018;18:737. [PMID: 30005630 DOI: 10.1186/s12885-018-4643-8] [Reference Citation Analysis]
306 Beckurts KT. Peri-operative and complication management for adenocarcinoma of the oesophagus and oesophagigastric junction. Recent Results Cancer Res 2010;182:143-53. [PMID: 20676878 DOI: 10.1007/978-3-540-70579-6_12] [Reference Citation Analysis]
307 Sato Y, Motoyama S, Nanjo H, Ito S, Yoshino K, Sasaki T, Kuribayashi K, Nagaki Y, Imai K, Saito H, Minamiya Y, Ogawa J. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy. Ann Surg Oncol 2013;20:3044-51. [PMID: 23645481 DOI: 10.1245/s10434-013-2983-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
308 Kataoka K, Nakamura K, Mizusawa J, Fukuda H, Igaki H, Ozawa S, Hayashi K, Kato K, Kitagawa Y, Ando N. Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer. Br J Surg 2015;102:1088-96. [PMID: 26095389 DOI: 10.1002/bjs.9839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
309 Hoshimoto S, Takeuchi H, Ono S, Sim MS, Huynh JL, Huang SK, Marzese DM, Kitagawa Y, Hoon DS. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome. J Thorac Oncol 2015;10:509-17. [PMID: 25514805 DOI: 10.1097/JTO.0000000000000441] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
310 Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, Saeki H, Morita M, Sakaguchi Y, Toh Y, Maehara Y. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42:351-358. [PMID: 22245924 DOI: 10.1007/s00595-011-0114-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
311 Wang Q, He XR, Shi CH, Tian JH, Jiang L, He SL, Yang KH. Hand-Sewn Versus Stapled Esophagogastric Anastomosis in the Neck: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Indian J Surg 2015;77:133-40. [PMID: 26139968 DOI: 10.1007/s12262-013-0984-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
312 Matkovic E, Schwalbe M, Matkowskyj KA. Pathologic Features of Esophageal and Gastric Malignancies. Cancer Treat Res 2016;168:17-43. [PMID: 29206017 DOI: 10.1007/978-3-319-34244-3_2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
313 Barzi A, Lenz HJ. Angiogenesis-related agents in esophageal cancer. Expert Opin Biol Ther 2012;12:1335-45. [PMID: 22860627 DOI: 10.1517/14712598.2012.707180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
314 Ishibashi Y, Dosaka-Akita H, Miyoshi E, Shindoh M, Miyamoto M, Kinoshita I, Miyazaki H, Itoh T, Kondo S, Nishimura M, Taniguchi N. Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions. Oncology 2005;69:301-10. [PMID: 16282710 DOI: 10.1159/000089680] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
315 Takeuchi H, Ozawa S, Ando N, Kitagawa Y, Ueda M, Kitajima M. Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2003;10:792-800. [PMID: 12900371 DOI: 10.1245/aso.2003.10.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
316 Engel S, Awerbuch A, Kwon D, Picado O, Yechieli R, Yakoub D, Portelance L. Optimal radiation dosing in concurrent neoadjuvant chemoradiation for resectable esophageal cancer: a meta-analysis. J Gastrointest Oncol 2019;10:391-9. [PMID: 31183187 DOI: 10.21037/jgo.2019.01.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
317 Kogo M, Suzuki A, Kaneko K, Yoneyama K, Imawari M, Kiuchi Y. Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer. Dig Dis Sci 2008;53:2415-21. [PMID: 18256935 DOI: 10.1007/s10620-007-0149-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
318 Takeuchi M, Takeuchi H, Fujisawa D, Miyajima K, Yoshimura K, Hashiguchi S, Ozawa S, Ando N, Shirahase J, Kitagawa Y. Incidence and risk factors of postoperative delirium in patients with esophageal cancer. Ann Surg Oncol. 2012;19:3963-3970. [PMID: 22699802 DOI: 10.1245/s10434-012-2432-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
319 Natsugoe S, Matsumoto M, Okumura H, Nakashima S, Sakamoto F, Sakita H, Baba M, Takao S, Aikou T. Bax and Bcl-X(L) expression are not related to prognosis in patients with advanced esophageal squamous cell carcinoma. Cancer Lett 2001;174:91-7. [PMID: 11675156 DOI: 10.1016/s0304-3835(01)00590-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
320 Yamashita H, Nakagawa K, Yamada K, Kaminishi M, Mafune K, Ohtomo K. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma. Dis Esophagus 2008;21:430-6. [PMID: 19125797 DOI: 10.1111/j.1442-2050.2007.00793.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
321 Morimoto M, Nakamura Y, Yasuda Y, Lefor AT, Nagaie T, Sata N, Hosoya Y, Horie H, Koinuma K. Serum Total Cholesterol Levels Would Predict Nosocomial Infections After Gastrointestinal Surgery. Indian J Surg 2015;77:283-9. [PMID: 26702235 DOI: 10.1007/s12262-015-1296-6] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
322 Kim HK, Kim S, Park JJ, Jeong JM, Mok YJ, Choi YH. Sentinel node identification using technetium-99m neomannosyl human serum albumin in esophageal cancer. Ann Thorac Surg 2011;91:1517-22. [PMID: 21377648 DOI: 10.1016/j.athoracsur.2011.01.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
323 Gabrielson S, Tsai JA, Celebioglu F, Nilsson M, Rouvelas I, Lindblad M, Bjäreback A, Tomson A, Axelsson R. Preoperative detection of sentinel lymph nodes with hybrid SPECT/computed tomography imaging may improve the accuracy of sentinel lymph node biopsies in patients with early stages of cancer of the oesophagus or gastro-oesophageal junction. Nucl Med Commun 2020;41:1153-60. [PMID: 32796448 DOI: 10.1097/MNM.0000000000001273] [Reference Citation Analysis]
324 Booka E, Takeuchi H, Suda K, Fukuda K, Nakamura R, Wada N, Kawakubo H, Kitagawa Y. Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancer. BJS Open 2018;2:276-84. [PMID: 30263978 DOI: 10.1002/bjs5.64] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
325 Tsubosa Y, Sato H, Tachimori Y, Hokamura N, Hosokawa M, Kinoshita Y, Daiko H, Udagawa H, Ueno M, Seto Y, Jinbo K, Kitagawa Y, Takeuchi H, Park M, Nagasaka S, Yamada H, Ota Y. Multi-institution retrospective study of the onset frequency of postoperative pneumonia in thoracic esophageal cancer patients. Esophagus 2014;11:126-35. [DOI: 10.1007/s10388-014-0423-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
326 Kitayama J, Kaisaki S, Ishigami H, Hidemura A, Nagawa H. Angleplasty in gastric tube reconstruction after esophagectomy. Diseases of the Esophagus 2009;22:418-21. [DOI: 10.1111/j.1442-2050.2008.00920.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
327 Koike M, Kodera Y, Itoh Y, Nakayama G, Fujiwara M, Hamajima N, Nakao A. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol. 2008;15:1977-1982. [PMID: 18408975 DOI: 10.1245/s10434-008-9901-6] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
328 Kanamoto A, Ninomiya I, Harada S, Tsukada T, Okamoto K, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H. Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma. Int J Oncol. 2016;49:1859-1869. [PMID: 27826618 DOI: 10.3892/ijo.2016.3712] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
329 Booka E, Tsubosa Y, Yokota T, Mayanagi S, Ishii K, Urakami K, Ohshima K, Ohnami S, Nagashima T, Yamaguchi K. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA. Esophagus 2021;18:743-52. [PMID: 33826001 DOI: 10.1007/s10388-021-00835-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
330 Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K, Maehara Y. In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol 2011;18:1757-65. [PMID: 21207167 DOI: 10.1245/s10434-010-1502-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
331 Yang H, Wang J, Huang Q, Zheng Y, Ela Bella A, Wang R, Fu J, Li A, Li X. Intraoperative ultrasonography for the identification of thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer. Dis Esophagus 2016;29:152-8. [PMID: 25604726 DOI: 10.1111/dote.12318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
332 Kurasawa Y, Maruoka Y, Sekiya H, Negishi A, Mukohyama H, Shigematsu S, Sugizaki J, Karakida K, Ohashi M, Ueno M, Michiwaki Y. Pneumonia prevention effects of perioperative oral management in approximately 25,000 patients following cancer surgery. Clin Exp Dent Res 2020;6:165-73. [PMID: 32250567 DOI: 10.1002/cre2.264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
333 Booka E, Tsubosa Y, Niihara M, Takagi W, Takebayashi K, Shimada A, Kitani T, Nagaoka M, Imai A, Kamijo T, Iida Y, Onitsuka T, Nakagawa M, Takeuchi H, Kitagawa Y. Risk factors for complications after pharyngolaryngectomy with total esophagectomy. Esophagus 2016;13:317-22. [PMID: 27695394 DOI: 10.1007/s10388-016-0533-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
334 Tinoco RC, Tinoco AC, El-Kadre LJ, Rios RA, Sueth DM, Pena FM. [Laparoscopic transhiatal esophagectomy: outcomes]. Arq Gastroenterol 2007;44:141-4. [PMID: 17962860 DOI: 10.1590/s0004-28032007000200011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
335 Cense HA, van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893-906. [PMID: 16997168 DOI: 10.1016/j.bpg.2006.03.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
336 McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008;98:888-93. [PMID: 18268490 DOI: 10.1038/sj.bjc.6604248] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
337 Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, Ishikawa H, Nonaka T, Takahashi T, Nakano T. Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy. J Radiat Res. 2013;54:706-711. [PMID: 23381956 DOI: 10.1093/jrr/rrt002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
338 Lambertz R, Drinhaus H, Schedler D, Bludau M, Schröder W, Annecke T. [Perioperative management of transthoracic oesophagectomies : Fundamentals of interdisciplinary care and new approaches to accelerated recovery after surgery]. Anaesthesist 2016;65:458-66. [PMID: 27245922 DOI: 10.1007/s00101-016-0179-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
339 Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, Mönig SP, Metzger R, Schicha H, Schmidt M. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg. 2009;250:888-894. [PMID: 19953708 DOI: 10.1097/sla.0b013e3181bc9c0d] [Cited by in Crossref: 87] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
340 Zenda S, Hironaka S, Taku K, Sato H, Hashimoto T, Hasuike N, Boku N, Tsubosa Y, Ono H, Nishimura T. OPTIMAL TIMING OF ENDOSCOPIC EVALUATION OF THE PRIMARY SITE OF ESOPHAGEAL CANCER AFTER CHEMORADIOTHERAPY OR RADIOTHERAPY: A RETROSPECTIVE ANALYSIS. Digestive Endoscopy 2009;21:245-51. [DOI: 10.1111/j.1443-1661.2009.00900.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
341 Booka E, Takeuchi H, Nishi T, Matsuda S, Kaburagi T, Fukuda K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Omori T, Kitagawa Y. The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer. Medicine (Baltimore) 2015;94:e1369. [PMID: 26287423 DOI: 10.1097/MD.0000000000001369] [Cited by in Crossref: 93] [Cited by in F6Publishing: 46] [Article Influence: 13.3] [Reference Citation Analysis]
342 Kumagai Y, Ishiguro T, Haga N, Kuwabara K, Kawano T, Ishida H. Hemodynamics of the reconstructed gastric tube during esophagectomy: assessment of outcomes with indocyanine green fluorescence. World J Surg. 2014;38:138-143. [PMID: 24196170 DOI: 10.1007/s00268-013-2237-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
343 Niihara M, Takeuchi H, Nakahara T, Saikawa Y, Takahashi T, Wada N, Mukai M, Kitagawa Y. Sentinel lymph node mapping for 385 gastric cancer patients. J Surg Res 2016;200:73-81. [PMID: 26233688 DOI: 10.1016/j.jss.2015.06.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
344 Fuchs HF, Broderick RC, Harnsberger CR, Divo FA, Coker AM, Jacobsen GR, Sandler BJ, Bouvet M, Horgan S. Intraoperative Endoscopic Botox Injection During Total Esophagectomy Prevents the Need for Pyloromyotomy or Dilatation. J Laparoendosc Adv Surg Tech A 2016;26:433-8. [PMID: 27043862 DOI: 10.1089/lap.2015.0575] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
345 Schröder W, Vallböhmer D, Bludau M, Banczyk A, Gutschow C, Hölscher AH. The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy? J Gastrointest Surg 2008;12:1163-7. [PMID: 18278537 DOI: 10.1007/s11605-008-0487-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
346 Matsuda S, Kawakubo H, Irino T, Kitagawa Y. Role sharing between minimally invasive oesophagectomy and organ preservation approach for surgically resectable advanced oesophageal cancer. Jpn J Clin Oncol 2021:hyab192. [PMID: 34891170 DOI: 10.1093/jjco/hyab192] [Reference Citation Analysis]
347 Natsugoe S, Ikeda M, Baba M, Churei H, Hiraki Y, Nakajo M, Aikou T; Kyushu Study Group for Adjuvant Therapy of Esophageal Cancer. Long-term survivors of advanced esophageal cancer without surgical treatment: a multicenter questionnaire survey in Kyushu, Japan. Dis Esophagus 2003;16:239-42. [PMID: 14641317 DOI: 10.1046/j.1442-2050.2003.00336.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
348 Guo L, Tang Y, Wang Y, Xu H. Prognostic Value of lncRNA NEAT1 as a New Biomarker in Digestive System Tumors: a Systematic Study and Meta-analysis. Expert Rev Mol Diagn 2021;21:91-9. [PMID: 33550874 DOI: 10.1080/14737159.2021.1874921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274-9. [PMID: 11943125 DOI: 10.1016/s0002-9610(02)00795-x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
350 Takeuchi H, Kawakubo H, Nakamura R, Fukuda K, Takahashi T, Wada N, Kitagawa Y. Clinical Significance of Sentinel Node Positivity in Patients with Superficial Esophageal Cancer. World J Surg. 2015;39:2941-2947. [PMID: 26296842 DOI: 10.1007/s00268-015-3217-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
351 Stein HJ, Siewert JR. Improved prognosis of resected esophageal cancer. World J Surg. 2004;28:520-525. [PMID: 15366737 DOI: 10.1007/s00268-004-7417-1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
352 Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H;  Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG). Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684-690. [PMID: 20932658 DOI: 10.1016/j.ijrobp.2010.06.033] [Cited by in Crossref: 202] [Cited by in F6Publishing: 184] [Article Influence: 16.8] [Reference Citation Analysis]
353 Lin M, Shen Y, Feng M, Tan L. Minimally invasive esophagectomy: Chinese experiences. J Vis Surg 2016;2:134. [PMID: 29078521 DOI: 10.21037/jovs.2016.07.20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
354 Zheng YZ, Zhao W, Hu Y, Ding-Lin XX, Wen J, Yang H, Liu QW, Luo KJ, Huang QY, Chen JY, Fu JH. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World J Gastroenterol 2015; 21(28): 8644-8652 [PMID: 26229406 DOI: 10.3748/wjg.v21.i28.8644] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
355 Usami S, Motoyama S, Matsuhashi T, Jin M, Maruyama K, Sato Y, Yoshino K, Nakatsu T, Saito H, Minamiya Y, Saito R, Ohnishi H, Ogawa J. Outcomes of endoscopic and surgical resection for a second primary cancer in the residual cervical esophagus after thoracic esophagectomy: Cancer of the residual cervical esophagus. Diseases of the Esophagus 2012;25:228-34. [DOI: 10.1111/j.1442-2050.2011.01239.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
356 Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791-800. [PMID: 15492560 DOI: 10.1097/01.sla.0000143123.24556.1c] [Cited by in Crossref: 273] [Cited by in F6Publishing: 242] [Article Influence: 15.2] [Reference Citation Analysis]
357 Nishimura K, Tanaka T, Tsubuku T, Matono S, Nagano T, Murata K, Aoyama Y, Yanagawa T, Shirouzu K, Fujita H. Reflux esophagitis after esophagectomy: impact of duodenogastroesophageal reflux. Dis Esophagus 2012;25:381-5. [PMID: 21967617 DOI: 10.1111/j.1442-2050.2011.01268.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
358 Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y. Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. Cancer Sci 2012;103:1617-24. [PMID: 22676270 DOI: 10.1111/j.1349-7006.2012.02355.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
359 Miyashita M, Tajiri T, Sasajima K, Makino H, Maruyama H, Nomura T, Futami R, Hagiwara N, Tsuchiya Y, Yamashita K. Response to preoperative chemotherapy affects prognosis in esophageal cancer. Dis Esophagus 2003;16:99-101. [PMID: 12823206 DOI: 10.1046/j.1442-2050.2003.00301.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]